Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial

Thoracic Cancer

Volumn 5, Issue 6, 2014, Pages 500-508

  Ko, Hui Ling ^a   Wang, Yu Shan ^a   Fong, Weng Lam ^a   Chi, Mau Shin ^a   Chi, Kwan Hwa ^a   Kao, Shang Jyh ^a,b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b Shin KongWu Ho Su Memorial Hospital   (Taiwan)

Author keywords

APOC1; Gene expression profiling; Inflammation associated genes; Lung cancer; RT PCR

Indexed keywords

APOLIPOPROTEIN C1; BIOLOGICAL MARKER; COMPLEMENTARY DNA; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MARKER GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84911949324     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12117     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Skrzypski M, Jassem E, Taron M etal. Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung. Clin Cancer Res 2008; 14: 4794-4799.
3. Reed CE, Graham A, Hoda RS etal. A simple two-gene prognostic model for adenocarcinoma of the lung. J Thorac Cardiovasc Surg 2008; 135: 627-634.
4. Raz DJ, Ray MR, Kim JY etal. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma. Clin Cancer Res 2008; 14: 5565-5570.
5. Liu L, Liao GQ, He P etal. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem Biophys Res Commun 2008; 372: 756-760.
6. Guo NL, Wan YW, Tosun K etal. Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res 2008; 14: 8213-8220.
7. Ko JH, Gu W, Lim I, Bang H, Ko EA, Zhou T. Ion channel gene expression in lung adenocarcinoma: potential role in prognosis and diagnosis. PLoS ONE 2014; 9: e86569.
8. Zhu CQ, Shih W, Ling CH, Tsao MS. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006; 59: 790-800.
9. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 2005; 11: 3974-3986.
10. Gugger M, Kappeler A, Vonlanthen S etal. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer 2001; 33: 229-239.
11. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181: 5791-5802.
12. Hsu PS, Wang YS, Huang SC etal. Improving detection accuracy of lung cancer serum proteomic profiling via two-stage training process. Proteome Sci 2011; 9: 20.
13. Wang YS, Chang HJ, Chang YC etal. Serum amyloid A as a predictive marker for radiation pneumonitis in lung cancer patients. Int J Radiat Oncol Biol Phys 2013; 85: 791-797.
14. Poon TCW. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics 2007; 4: 51-65.
15. Mortier A, Gouwy M, Van Damme J, Proost P. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res 2011; 317: 642-654.
16. Connor TJ, Starr N, O'Sullivan JB, Harkin A. Induction of indolamine 2, 3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? Neurosci Lett 2008; 441: 29-34.
17. Berbée JFP, Havekes LM, Rensen PCN. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 2005; 11: 97-103.
18. Chechlinska M, Kowalewska M, Nowak R. Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nat Rev Cancer 2010; 10: 2-3.
19. Schippers EF, Berbée JF, van Disseldorp IM etal. Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery. Intensive Care Med 2008; 34: 1492-1497.
20. Takano S, Yoshitomi H, Togawa A etal. Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells. Oncogene 2008; 27: 2810-2822.
21. Bihl M, Tamm M, Nauck M, Wieland H, Perruchoud AP, Roth M. Proliferation of human non-small-cell lung cancer cell lines: role of interleukin-6. Am J Respir Cell Mol Biol 1998; 19: 606-612.
22. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003; 24: 25-29.
23. Kwon KA, Kim SH, Oh SY etal. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 2010; 10: 203.
24. Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267: 204-215.
25. Westerterp M, Van Eck M, de Haan W etal. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages. Atherosclerosis 2007; 195: e9-e16.
26. Lauer SJ, Walker D, Elshourbagy NA, Reardon CA, Levy-Wilson B, Taylor JM. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J Biol Chem 1988; 263: 7277-7286.
27. Shulman RS, Herbert PN, Wehrly K, Fredrickson DS. Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins. J Biol Chem 1975; 250: 182-190.
28. Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 2004; 64: 1834-1842.
29. Chen YC, Pohl G, Wang TL etal. Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Cancer Res 2005; 65: 331-337.
30. Sato N, Fukushima N, Chang R, Matsubayashi H, Goggins M. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. Gastroenterology 2006; 130: 548-565.
31. Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 2005; 4: 1742-1751.
32. Goncalves A, Esterni B, Bertucci F etal. Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 2006; 25: 981-989.
33. Ehmann M, Felix K, Hartmann D etal. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 2007; 34: 205-214.
34. McShane LM, Altman DG, Sauerbrei W. Identification of clinically useful cancer prognostic factors: what are we missing? J Natl Cancer Inst 2005; 97: 1023-1025.